Effects of Dry Needling on Spasticity, Functions, Balance and Independence Level in Patients With Stroke

Eastern Mediterranean University

Status: Completed

Conditions: Stroke; CVA (Cerebrovascular Accident)

Treatments: Other: Neurodevelopemental therapy (NDT) and dry needling; Other: Neurodevelopemental therapy (NDT)

Study type: Interventional

Funder types: Other

Identifiers

NCT03863678

KK 1695

Details and patient eligibility

About

The aim of this study is to investigate the effects of dry needling method in addition to neurodevelopmental therapy on spasticity, upper and lower extremity functions, balance and independence level in patients with stroke who have spasticity.

Full description

The aim of this study is to investigate the effects of dry needling method in addition to neurodevelopmental therapy on spasticity, upper and lower extremity functions, balance and independence level in patients with stroke who have spasticity. In this study, goniometric measurement, Modified Ashworth Scale, Nine Hole Peg Test, 10 Meter Walking Test, Fullerton Advanced Balance Scale and Functional Independence Scale will be used for outcome measurement. The participants will be randomised into two groups; Group 1 will receive NDT and Group 2 will receive both NDT and dry needling therapy. Both groups will be given 45 minutes of NDT, 3 sessions per week in 4 weeks period (total of 12 sessions). Group 2 will also receive dry needling therapy 3 sessions per week in 4 weeks period (total of 12 sessions). Dry needling will be applied on M. Gastrocnemius, M.Quadriceps, M.Flexor Carpi Radialis and M.Biceps Brachii muscles. The application time on each muscle will be 60 seconds (sec). Fast in and fast out technique will be used for dry needling therapy. All patients will be measured before treatment (T1) and after treatment (T3). An inter-measurement will be performed after the treatment session (T2) in addition to T1 and T3 measurements in the Group 2, to evaluate the acute effects of dry needling therapy. No additional treatment will be applied to the Group 1. All assessments will be performed by the same physiotherapist.

Enrollment: 42 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• First time stroke,
• Patients who has spasticity due to stroke,
• At least 6 months after stroke,
• Individuals between the ages of 18-75 will be included in the study.

Exclusion criteria

• Any contraindication for dry needling (eg, anticoagulants, infections, bleeding, etc.),
• Having diabetes,
• Having cardiovascular diseases,
• Having any other neurological problems,
• Application of Botox within 6 months prior to the study,
• Individuals included in another treatment program will not be included in the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

42 participants in 2 patient groups

Neurodevelopmental therapy

Experimental group

Description:

Group 1 will only receive Neurodevelopmental therapy (NDT), for 12 sessions.

Treatment:

Other: Neurodevelopemental therapy (NDT)

Neurodevelopemental therapy and dry needling therapy

Experimental group

Description:

Group 2 will receive Neurodevelopmental therapy (NDT) and dry needling therapy, for 12 sessions.

Treatment:

Other: Neurodevelopemental therapy (NDT) and dry needling